Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis

Chest

Volumn 130, Issue 4, 2006, Pages 982-988

  Antoniou, Katerina M ^a   Tzouvelekis, Argyris ^b   Alexandrakis, Michael G ^a   Sfiridaki, Katerina ^c   Tsiligianni, Ioanna ^a   Rachiotis, George ^d   Tzanakis, Nikolaos ^a   Bouros, Demosthenes ^b   Milic Emili, Joseph ^e   Siafakas, Nikolaos M ^a,f  

^a UNIVERSITY OF CRETE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c Venizelion General Hospital   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Angiogenesis; Angiostasis; CXC chemokines; Growth related gene ; Interferon inducible protein 10; Interferon inducible T cell chemoattractant; Monokine induced by interferon

Indexed keywords

ALPHA CHEMOKINE; ANGIOSTATIC PROTEIN; CHEMOATTRACTANT; CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON INDUCIBLE T CELL ALPHA CHEMOTTRACTANT; GROWTH RELATED GENE ALPHA PROTEIN; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IDIOPATHIC DISEASE; LUNG FIBROSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPIROMETRY; UPREGULATION;

EID: 33750085558     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.4.982     Document Type: Article

References (33)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165:277-304
2. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis, American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173
3. Strieter RM, Burdick MD, Gomperts BN, et al. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 2005; 16:593-609
4. Turner-Warwick M. Precapillary systemic-pulmonary anastomoses. Thorax 1963; 18:225-237
5. Keane MP, Arenberg DA, Lynch JP III, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997; 159:1437-1443
6. Keane MP, Belperio JA, Burdick MD, et al. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164:2239-2242
7. Keane MP, Belperio JA, Arenberg DA, et al. IFN-γ-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 1999; 163:5686-5692
8. Cassan SM, Divertie MB, Brown AL Jr. Fine structural morphometry on biopsy specimens of human lung: 2. Diffuse idiopathic pulmonary fibrosis. Chest 1974; 65:275-278
9. Gracey DR, Divertie MB, Brown AL Jr. Alveolar-capillary membrane in idiopathic interstitial pulmonary fibrosis: electron microscopic study of 14 cases. Am Rev Respir Dis 1968; 98:16-21
10. Renzoni EA, Walsh DA, Salmon M, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 2003; 167:438-443
11. Keane MP. Angiogenesis and pulmonary fibrosis: feast or famine? Am J Respir Crit Care Med 2004; 170:207-209
12. Renzoni EA. Neovascularization in idiopathic pulmonary fibrosis: too much or too little? Am J Respir Crit Care Med 2004; 169:1179-1180
13. Ebina M, Shimizukawa M, Shibata N, et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004; 169:1203-1208
14. Meyer KC, Cardoni A, Xiang ZZ. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 2000; 135:332-338
15. Cosgrove GP, Brown KK, Schiemann WP, et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 2004; 170:242-251
16. Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J: 1998; 12:716-738
17. Tsiligianni I, Antoniou KM, Kyriakou D, et al. Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med 2005; 5:8
18. Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-445
19. Strieter RM, Belperio JA, Keane MP. CXC chemokines in angiogenesis related to pulmonary fibrosis. Chest 2002; 122:298S-301S
20. Agostini C, Cassatella M, Zambello R, et al. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol 1998; 161:6413-6420
21. Miotto D, Christodoulopoulos P, Olivenstein R, et al. Expression of IFN-γ-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotarin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 2001; 107:664-670
22. Katoh S, Fukushima K, Matsumoto N, et al. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia. Int Arch Allergy Immunol 2005; 137:229-235
23. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
24. Report of the European Society of Pneumonology Task Group 1989. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989; 2:561-585
25. Ziegenhagen MW, Schrum S, Zissel G, et al. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med 1998; 46:223-231
26. Yokoyama T, Kanda T, Kobayashi I, et al. Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis. J Med 1995; 26:209-219
27. Ziegenhagen MW, Zabel P, Zissel G, et al. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med 1998; 157:762-768
28. Ziegenhagen MW, Rothe ME, Schlaak M, et al. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003; 21:407-413
29. Simler NR, Brenchley PE, Horrocks AW, et al. Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax 2004; 59:581-585
30. Nakayama S, Mukae H, Ishii H, et al. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and non specific interstitial pneumonia. Respir Med 2005; 99:1145-1151
31. Tzouvelekis A, Kouliatsis G, Anevlavis S, et al. Serum biomarkers in interstitial lung diseases. Respir Res 2005; 6:78
32. Antoniou KM, Tzouvelekis A, Alexandrakis MG, et al. Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res 2006; 26:400-405
33. Antoniou KM, Tsiligianni I, Tzanakis N, et al. Perform downregulation and adhesion molecules activation in pulmonary sarcoidosis: an induced sputum and bronchoalveolar lavage study. Chest 2006; 129:1592-1598